GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research i
nclude:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

< prev 1    3  4  5  6  7  8  9  10  
Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth
7/3/2015 | published by: GBI Research
... chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity. This has been attributed to a range of factors, including economic development, increasing urbanization, ...  |  read more...
USD 4,995
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
7/1/2015 | published by: GBI Research
... affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, ...  |  read more...
USD 4,995
Frontier Pharma: Versatile Innovation in Oncology - Identifying and Commercializing Versatile First-in-Class Innovation
7/1/2015 | published by: GBI Research
... human body. These indications are the leading cause of death in economically developed countries and the second-leading cause of death in developing countries and present a major global health burden. Across the pharmaceutical industry as ...  |  read more...
USD 6,995
Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments
7/1/2015 | published by: GBI Research
... proliferation of plasma cells in the bone marrow. It is the second-most frequently diagnosed hematological malignancy, with an annual prevalence in the US of about 45,000. The disease is considered incurable, although the past decade ...  |  read more...
USD 4,995
Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation
6/1/2015 | published by: GBI Research
... people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market. A highly active pancreatic ...  |  read more...
USD 6,995
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation
5/1/2015 | published by: GBI Research
... range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations is significant. GBI Research analysis ...  |  read more...
USD 6,995
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs
5/1/2015 | published by: GBI Research
... its latest research, Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs, which provides in-depth analysis of Rheumatoid Arthritis (RA) ...  |  read more...
USD 4,995
Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation
5/1/2015 | published by: GBI Research
... 84 molecules across all stages of development. GBI Research’s analysis revealed a high degree of innovation and diversity in this indication, with 70% of the pipeline being first-in-class products, acting on 13 first-in-class targets. This ...  |  read more...
USD 6,995
Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth
5/1/2015 | published by: GBI Research
... Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth, which provides insights into psoriasis therapeutics in the Asia-Pacific (APAC) market. For the purposes of this report, APAC refers to ...  |  read more...
USD 4,995
MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies
4/2/2015 | published by: GBI Research
... Operational Efficiency, with Growth Driven by Developing Economies discusses the market, competitive landscape, and trends for three MRI systems market segments: High-field, Mid-field, and Low-field MRI systems. It provides comprehensive information on the key trends ...  |  read more...
USD 3,500
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Asia-Pacific
4/1/2015 | published by: GBI Research
... monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: ...  |  read more...
USD 1,750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Americas
3/9/2015 | published by: GBI Research
... stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: US, Brazil and Canada. It uses data and information sourced from proprietary ...  |  read more...
USD 1,750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Europe
3/5/2015 | published by: GBI Research
... stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: Germany, France, UK, Italy and Spain. It uses data and information sourced ...  |  read more...
USD 1,750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Asia-Pacific
3/5/2015 | published by: GBI Research
... stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: China, Japan, India and Australia. It uses data and information sourced from ...  |  read more...
USD 1,750
Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations
2/28/2015 | published by: GBI Research
... report,""Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations"".The asthma therapeutics market is forecast to grow marginally over the forecast period across the ...  |  read more...
USD 4,995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Americas
2/1/2015 | published by: GBI Research
... the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006–2020 ...  |  read more...
USD 1,750
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches
1/31/2015 | published by: GBI Research
... in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches"". The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, ...  |  read more...
USD 4,995
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics
1/31/2015 | published by: GBI Research
... research, “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in ...  |  read more...
USD 4,995
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation
1/31/2015 | published by: GBI Research
... of molecular targets. GBI Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree of innovation. This is in stark ...  |  read more...
USD 6,995
Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation
12/31/2014 | published by: GBI Research
... majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such a high proportion of drugs at the earliest stages of development would, in other indications, provide hope of ...  |  read more...
USD 6,995
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth
12/31/2014 | published by: GBI Research
... progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands ...  |  read more...
USD 4,995
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
12/31/2014 | published by: GBI Research
... the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast between the market and ...  |  read more...
USD 6,995
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Europe (Germany, France, Italy, UK and Spain)
12/20/2014 | published by: GBI Research
... Italy, UK and Spain)” provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data ...  |  read more...
USD 1,750
Frontier Pharma: Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse ...  |  read more...
USD 6,995
Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in ...  |  read more...
USD 6,995
< prev 1    3  4  5  6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!